Medicines for Malaria Venture (MMV)
@mmv.org
A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.
Calling all mid-career African researchers: the application deadline for the SAHRI Fellowship Programme is fast approaching. A fully funded opportunity to build leadership in biomedical innovation and clinical research. Apply by 1 February bit.ly/4qfTdT6
January 13, 2026 at 5:13 PM
Calling all mid-career African researchers: the application deadline for the SAHRI Fellowship Programme is fast approaching. A fully funded opportunity to build leadership in biomedical innovation and clinical research. Apply by 1 February bit.ly/4qfTdT6
Can #AI accelerate the discovery of next-gen antimalarials to keep us ahead of resistance and bring us closer to zero #malaria deaths? Sithulisiwe Ngwenya explains how dd4gh, an AI-powered platform in development by MMV & @deepmirror.bsky.social, can support her drug discovery research.
January 13, 2026 at 2:48 PM
Can #AI accelerate the discovery of next-gen antimalarials to keep us ahead of resistance and bring us closer to zero #malaria deaths? Sithulisiwe Ngwenya explains how dd4gh, an AI-powered platform in development by MMV & @deepmirror.bsky.social, can support her drug discovery research.
This Sunday, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, where he'll be running in the Hong Kong Marathon in support of MMV’s mission to discover, develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3LJ3esD
Running Hong Kong marathon to fight Malaria with MMV
Help Camille Gourjault raise money to support MMV Medicines for Malaria Venture
bit.ly
January 12, 2026 at 5:45 PM
This Sunday, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, where he'll be running in the Hong Kong Marathon in support of MMV’s mission to discover, develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3LJ3esD
Child-friendly #malaria meds are essential to elimination.
@who.int prequalification of paediatric primaquine formulations is a major step forward for efficacious, age-appropriate treatment for children, helping prevent relapse and reduce transmission 👉 bit.ly/4ptG6w9
@who.int prequalification of paediatric primaquine formulations is a major step forward for efficacious, age-appropriate treatment for children, helping prevent relapse and reduce transmission 👉 bit.ly/4ptG6w9
Un traitement contre le paludisme pédiatrique suscite l’espoir en Afrique
Des experts saluent la formulation d’une version spécifique de la primaquine dédiée aux bébés chez qui elle traite la maladie, stoppe la transmission et prévient les rechutes.
bit.ly
January 12, 2026 at 3:13 PM
Child-friendly #malaria meds are essential to elimination.
@who.int prequalification of paediatric primaquine formulations is a major step forward for efficacious, age-appropriate treatment for children, helping prevent relapse and reduce transmission 👉 bit.ly/4ptG6w9
@who.int prequalification of paediatric primaquine formulations is a major step forward for efficacious, age-appropriate treatment for children, helping prevent relapse and reduce transmission 👉 bit.ly/4ptG6w9
How can we go farther and faster together in the fight against #malaria? By leaning into our role as impatient optimists.
At #ASTMH25, MMV and @gatesfoundation.bsky.social reaffirmed our belief in a malaria-free future and a bold, science-driven path forward. 🎥 bit.ly/44OOyOP
At #ASTMH25, MMV and @gatesfoundation.bsky.social reaffirmed our belief in a malaria-free future and a bold, science-driven path forward. 🎥 bit.ly/44OOyOP
January 9, 2026 at 9:12 AM
How can we go farther and faster together in the fight against #malaria? By leaning into our role as impatient optimists.
At #ASTMH25, MMV and @gatesfoundation.bsky.social reaffirmed our belief in a malaria-free future and a bold, science-driven path forward. 🎥 bit.ly/44OOyOP
At #ASTMH25, MMV and @gatesfoundation.bsky.social reaffirmed our belief in a malaria-free future and a bold, science-driven path forward. 🎥 bit.ly/44OOyOP
Working on a project that could help expand MMV’s drug discovery pipeline and the global antimalarial toolbox? Our 23rd call for proposals is now open for compounds addressing key #malaria prevention, treatment and elimination needs. Deadline: 27 Feb. 👉 bit.ly/3XFUG8n
January 7, 2026 at 1:21 PM
Working on a project that could help expand MMV’s drug discovery pipeline and the global antimalarial toolbox? Our 23rd call for proposals is now open for compounds addressing key #malaria prevention, treatment and elimination needs. Deadline: 27 Feb. 👉 bit.ly/3XFUG8n
Can we afford #malaria eradication? Put benefits above costs & the answer is yes. Eradication will save lives and deliver major social & #economic returns. At #ASTMH25, Prof. Nonvignon underscored why we cannot afford not to pursue a malaria-free future 👉 bit.ly/4pzptQg
Gates Foundation & MMV at ASTMH 2025 (5/7)
Malaria eradication in our lifetime: don’t stop believing. A sponsored MMV and Gates Foundation symposium at the ASTMH Annual Meeting. Prof. Justice Nonvignon, Management Sciences for Health and University of Ghana – Can we afford elimination? Can we afford NOT to achieve elimination? The bets we place on accelerating malaria elimination cannot miss the mark
bit.ly
January 7, 2026 at 1:20 PM
Can we afford #malaria eradication? Put benefits above costs & the answer is yes. Eradication will save lives and deliver major social & #economic returns. At #ASTMH25, Prof. Nonvignon underscored why we cannot afford not to pursue a malaria-free future 👉 bit.ly/4pzptQg
What can endemic countries learn from Zambia’s progress towards #malaria elimination? At #ASTMH25, Dr Busiku Hamainza shared how strong leadership, scaled interventions, real-time data and partner support are driving progress. 🎥 bit.ly/4rQ4bzJ
Gates Foundation & MMV at ASTMH 2025 (6/7)
Malaria eradication in our lifetime: don’t stop believing. A sponsored MMV and Gates Foundation symposium at the ASTMH Annual Meeting. Dr Busiku Hamainza, Ministry of Health, Zambia – We never stopped believing: Zambia’s 10+ year journey to eliminate malaria sub-nationally through targeted MDA approaches – lessons learned and gaps identified
bit.ly
January 7, 2026 at 11:26 AM
What can endemic countries learn from Zambia’s progress towards #malaria elimination? At #ASTMH25, Dr Busiku Hamainza shared how strong leadership, scaled interventions, real-time data and partner support are driving progress. 🎥 bit.ly/4rQ4bzJ
How can we eliminate the #malaria parasite with existing & new tools? Modelling helps assess strategies for developing and deploying interventions and guides R&D and access decisions. At #ASTMH25, Prof. Melissa Penny showed how it can accelerate progress 👉🎥 bit.ly/4rJzKea
Gates Foundation & MMV at ASTMH 2025 (4/7)
Malaria eradication in our lifetime: don’t stop believing. A sponsored MMV and Gates Foundation symposium at the ASTMH Annual Meeting. Prof. Melissa Penny, The Kids Research Institute Australia – Modelling the path to elimination: considerations regarding the relative contribution of new elimination accelerators
bit.ly
January 7, 2026 at 11:17 AM
How can we eliminate the #malaria parasite with existing & new tools? Modelling helps assess strategies for developing and deploying interventions and guides R&D and access decisions. At #ASTMH25, Prof. Melissa Penny showed how it can accelerate progress 👉🎥 bit.ly/4rJzKea
Current #malaria prevention tools offer considerable protection, but new options are needed to simplify delivery and extend protection further. At #ASTMH25, Prof. Amewu highlighted the big bets driving next-gen prevention tools 🎥 bit.ly/3XHQswZ
Gates Foundation & MMV at ASTMH 2025 (3/7)
Malaria eradication in our lifetime: don’t stop believing. A sponsored MMV and Gates Foundation symposium at the ASTMH Annual Meeting. Prof. Richard Amewu, University of Ghana – May the science be with you: the next decade of R&D for new prevention tools will hold one of the keys to accelerating malaria elimination
bit.ly
January 7, 2026 at 11:16 AM
Current #malaria prevention tools offer considerable protection, but new options are needed to simplify delivery and extend protection further. At #ASTMH25, Prof. Amewu highlighted the big bets driving next-gen prevention tools 🎥 bit.ly/3XHQswZ
Alan Magill believed that a business-as-usual approach to #malaria elimination is not enough. At #ASTMH25, MMV and
@gatesfoundation.bsky.social put his vision into a contemporary context, reinforcing our shared belief that eradication is possible in our lifetime. 🎥👉 bit.ly/4oFwlus
@gatesfoundation.bsky.social put his vision into a contemporary context, reinforcing our shared belief that eradication is possible in our lifetime. 🎥👉 bit.ly/4oFwlus
Gates Foundation & MMV at ASTMH 2025 (2/7)
Malaria eradication in our lifetime: don’t stop believing. A sponsored MMV and Gates Foundation symposium at the ASTMH Annual Meeting. Dr Tim Wells, MMV, Switzerland – Framing the path to elimination: Alan Magill’s vision for extirpating the human parasite reservoir
bit.ly
January 7, 2026 at 11:05 AM
Alan Magill believed that a business-as-usual approach to #malaria elimination is not enough. At #ASTMH25, MMV and
@gatesfoundation.bsky.social put his vision into a contemporary context, reinforcing our shared belief that eradication is possible in our lifetime. 🎥👉 bit.ly/4oFwlus
@gatesfoundation.bsky.social put his vision into a contemporary context, reinforcing our shared belief that eradication is possible in our lifetime. 🎥👉 bit.ly/4oFwlus
Despite setbacks & emerging threats, progress against #malaria continues.
Since 2000, billions of cases & millions of deaths have been averted & more countries are now malaria-free. Cabo Verde, Egypt, Georgia, Suriname & Timor-Leste show that zero malaria is possible.
Since 2000, billions of cases & millions of deaths have been averted & more countries are now malaria-free. Cabo Verde, Egypt, Georgia, Suriname & Timor-Leste show that zero malaria is possible.
January 7, 2026 at 11:04 AM
Despite setbacks & emerging threats, progress against #malaria continues.
Since 2000, billions of cases & millions of deaths have been averted & more countries are now malaria-free. Cabo Verde, Egypt, Georgia, Suriname & Timor-Leste show that zero malaria is possible.
Since 2000, billions of cases & millions of deaths have been averted & more countries are now malaria-free. Cabo Verde, Egypt, Georgia, Suriname & Timor-Leste show that zero malaria is possible.
#Malaria is often seen as inevitable, but it doesn’t have to be. Phase 3 results for GanLum, developed by Novartis & MMV, could further expand the antimalarial toolbox. But funding & political will remain the biggest barriers to access and #innovation 👉 bit.ly/3MIZabP
The end of malaria
How politics, not parasites, became the biggest threat in the fight against malaria
bit.ly
December 19, 2025 at 2:11 PM
#Malaria is often seen as inevitable, but it doesn’t have to be. Phase 3 results for GanLum, developed by Novartis & MMV, could further expand the antimalarial toolbox. But funding & political will remain the biggest barriers to access and #innovation 👉 bit.ly/3MIZabP
Scenes from last week’s co-creation workshop in Accra, where MMV & @deepmirror.bsky.social convened a group of Africa-based researchers convened to learn about & shape the continued development of the AI-powered Drug Discovery for Global Health platform. More 👉 bit.ly/4qeyz55
December 19, 2025 at 2:09 PM
Scenes from last week’s co-creation workshop in Accra, where MMV & @deepmirror.bsky.social convened a group of Africa-based researchers convened to learn about & shape the continued development of the AI-powered Drug Discovery for Global Health platform. More 👉 bit.ly/4qeyz55
Children’s medicines lag nearly a decade behind adult treatments.
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
December 19, 2025 at 1:20 PM
Children’s medicines lag nearly a decade behind adult treatments.
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
@who.int’s GAP-f network is working to close this gap. Its recent #malaria PADO exercise – supported by MMV – set a research agenda to better address children’s needs.
Report 👉 bit.ly/4pyfMBN
This year proved we can regain momentum against #malaria. To defeat it, we need broader access and new #innovations. MMV's CEO Martin Fitchet shares what’s needed in 2026 to accelerate progress through innovation & partnership.
December 19, 2025 at 12:21 PM
This year proved we can regain momentum against #malaria. To defeat it, we need broader access and new #innovations. MMV's CEO Martin Fitchet shares what’s needed in 2026 to accelerate progress through innovation & partnership.
The @gatesfoundation.bsky.social Goalkeepers Report warns child deaths are rising for the first time this century. Shrinking global health funding puts millions more at risk. For #malaria, the message is urgent: strengthen prevention, treatment & equitable access 👉 bit.ly/48rzNEc
2025 Goalkeepers Report | Ending Preventable Child Deaths with Primary Healthcare, Vaccines, and Next-Gen Innovations
Millions of children’s lives are at stake—without action, global aid cuts could lead to more child deaths over the next 20 years. But that future isn’t inevitable. If we act now—by getting proven, low...
bit.ly
December 19, 2025 at 11:59 AM
The @gatesfoundation.bsky.social Goalkeepers Report warns child deaths are rising for the first time this century. Shrinking global health funding puts millions more at risk. For #malaria, the message is urgent: strengthen prevention, treatment & equitable access 👉 bit.ly/48rzNEc
A powerful trio of #malaria prevention tools – vector control, chemoprevention & vaccines – helped protect millions last year.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
December 18, 2025 at 1:51 PM
A powerful trio of #malaria prevention tools – vector control, chemoprevention & vaccines – helped protect millions last year.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
MMV works with national malaria control programmes & African manufacturers to continue expanding access to SMC for children and pregnant women.
The #WorldMalariaReport is clear: drug resistance is advancing. Our response must be just as clear: new meds with new mechanisms of action.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
December 18, 2025 at 1:49 PM
The #WorldMalariaReport is clear: drug resistance is advancing. Our response must be just as clear: new meds with new mechanisms of action.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
Collaboration, commitment & funding can keep us ahead of resistance & help deliver next-gen meds to ensure #malaria is no longer a threat.
On 18 January, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, running the Hong Kong Marathon in support of MMV’s mission to develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3KMhT5K
Running Hong Kong marathon to fight Malaria with MMV
Help Camille Gourjault raise money to support MMV Medicines for Malaria Venture
bit.ly
December 17, 2025 at 12:48 PM
On 18 January, graduate researcher Camille Gourjault is taking the fight against #malaria from the lab to the streets, running the Hong Kong Marathon in support of MMV’s mission to develop and deliver the next generation of antimalarials. Learn more 👉 bit.ly/3KMhT5K
Antimalarial drug resistance won’t wait, and neither should we. At the #WorldMalariaReport launch in the UK Parliament, MMV’s Cristina Donini highlighted our efforts to stay one step ahead of resistance and the role UK science & innovation play in the fight against #malaria.
December 16, 2025 at 1:55 PM
Antimalarial drug resistance won’t wait, and neither should we. At the #WorldMalariaReport launch in the UK Parliament, MMV’s Cristina Donini highlighted our efforts to stay one step ahead of resistance and the role UK science & innovation play in the fight against #malaria.
Can AI advance #malaria elimination & support an inclusive global health system? In @devex.com, MMV experts highlight 3 opportunities:
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
3 ways AI can support drug innovation and global research equity
Opinion: Artificial intelligence could be a crucial multiplier in the fight against malaria. Researchers from Medicines for Malaria Venture explore how to harness its power while ensuring endemic-coun...
bit.ly
December 10, 2025 at 9:48 AM
Can AI advance #malaria elimination & support an inclusive global health system? In @devex.com, MMV experts highlight 3 opportunities:
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
• Faster next-gen drug discovery
• Co-creating innovation with endemic-country researchers
• Turning complex data into actionable insights
More 👉 bit.ly/3Mxkilk
Quality-assured antimalarials made locally are vital to reducing the #malaria burden in Africa.
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
First procurement of a preventive antimalarial from Swipha, a Nigerian manufacturer | Medicines for Malaria Venture
MMV’s technical support helps Swipha deliver malaria medicines to pregnant Nigerian women
bit.ly
December 9, 2025 at 11:57 AM
Quality-assured antimalarials made locally are vital to reducing the #malaria burden in Africa.
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
With MMV support, Swipha Nigeria’s SP has achieved @who.int prequalification, and the US Gov has procured 5M doses, protecting +1.6M pregnant women in Nigeria.
More 👉 bit.ly/3MhXUfT
Cabo Verde went from #malaria once being the leading cause of death to earning @who.int certification as malaria-free in 2024. A new @gatesfoundation.bsky.social article highlights key lessons: political will, collaboration, smart investment & strong health systems 👉 bit.ly/4pI2tOV
What can the world learn from Cabo Verde’s fight against malaria?
Cabo Verde’s decades-long effort to eliminate malaria shows how persistence, partnership, and local leadership can create a model for global health progress.
bit.ly
December 5, 2025 at 10:29 AM
Cabo Verde went from #malaria once being the leading cause of death to earning @who.int certification as malaria-free in 2024. A new @gatesfoundation.bsky.social article highlights key lessons: political will, collaboration, smart investment & strong health systems 👉 bit.ly/4pI2tOV
The @who.int 2025 World malaria report brings a clear message: drug resistance threatens to undo hard-won gains against #malaria. With progress stalling, we must double down on innovation, surveillance and long-term commitment to stay ahead of resistance 👉 bit.ly/48JynVs
December 4, 2025 at 9:30 AM
The @who.int 2025 World malaria report brings a clear message: drug resistance threatens to undo hard-won gains against #malaria. With progress stalling, we must double down on innovation, surveillance and long-term commitment to stay ahead of resistance 👉 bit.ly/48JynVs